GAVI Support for Cholera Vaccine Could Have Far Reaching Benefits

David A. Sack, MD

Professor | Johns Hopkins Bloomberg School of Public Health
GAVI Alliance

The November 22, 2013 GAVI decision to commit funds to the stockpile of oral cholera vaccines (OCVs) is a huge step in the eventual control of this disease, which infects 2-3 million persons each year and kills over 100,000.